COMPANY INFO
ImaGEN Inc. is a research and development company founded in 2004 that specializes in chemical hydride fuel cell hydrogen technologies. Led by CEO Ron Seftick, the company develops green, on-site, and on-demand hydrogen generation systems primarily for fuel cell electric vehicles and other applications. ImaGEN Inc. has around 6 employees (as of 2014) and is headquartered in Columbia, South Carolina, with its website at https://www.imagen-power.com.
Imagen Technologies, Inc. is a healthcare technology company founded in 2015, specializing in medical image analysis using artificial intelligence. Headquartered in New York, United States, Imagen leverages cutting-edge AI to transform diagnostic workflows and improve patient outcomes. Co-founded by Robert Lindsey and Alex Dresner, the company has scaled to over 140 employees and plays a pioneering role at the intersection of artificial intelligence and healthcare.
Imagen Technologies, Inc. has maintained an aggressive funding strategy to support its rapid growth and innovation in the healthcare AI space. To date, the company has successfully raised a total of $59.7M across four funding rounds. Key milestones in its funding journey include significant investments to fuel early product development, market expansion, and recent acceleration of both technology and commercial efforts. With prominent venture capital participation and a clear vision for the future of healthcare diagnostics, Imagen Technologies’ fundraising approach has centered on strategic capital raising to drive scaling and market leadership.
This Series C round was raised to accelerate product development, power the go-to-market strategy, and expand into new markets. The round was led by Summit Partners with participation from existing investor NFX, reflecting strong confidence in Imagen Technologies’ potential to redefine medical image analysis.
The Series B round was focused on enabling market expansion and further growth. This round was led by Downing and Cambridge Innovation Capital, bringing in additional resources for business development and expansion into new healthcare markets.
This Series A funding was dedicated to product development and scaling of operations. The capital enabled Imagen Technologies to advance its proprietary AI-powered diagnostic tools and scale its team to support early market entry.
Seed funding provided the necessary resources for the initial launch and early development of Imagen Technologies’ core technology platform.
Downing Ventures is a well-regarded venture capital firm focused on technology and healthcare investments. Downing played a key role in Imagen Technologies funding by backing the Series B round, providing both capital and strategic guidance as the company entered a phase of aggressive market expansion.
Cambridge Innovation Capital, known for its investments in high-tech and life science ventures, co-led the Series B for Imagen Technologies. The firm contributed vital financial resources and sector expertise to propel Imagen’s growth in the competitive healthcare AI market.
Guinness Asset Management participated in investment rounds for Imagen Technologies, supplying additional funding and leveraging its extensive network to support the company’s continued scaling and innovation.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Imagen Technologies, Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.